Molecular features evaluation of metastatic foci as the basis for metastatic breast cancer treatment personalization. Is there a place of CDK4/6-inhibitors in late-line therapy after chemotherapeutic regimens?

Những quyển sách tương tự

• Role of pre-metastatic niche in organ specificity of breast cancer metastasis. Influence on metastatic potential as a basis for CDK4/6-inhibition efficacy in early therapy of disseminated hormone-receptor-positive disease
  Bằng: A. I. Stukan, et al.
  Được phát hành: (2021-12-01)
• Efficacy of the immune checkpoint inhibitor nivolumab in the treatment of advanced hepatocellular carcinoma with the exhausted possibilities of therapy with tyrosine kinase inhibitors
  Bằng: A. Yu. Goryainova, et al.
  Được phát hành: (2021-12-01)
• Analysis of the clinical efficacy of the cyclin- dependent kinase inhibitor 4/6 Abemaciclib on the clinical case of a male with hormonereceptor- positive breast cancer
  Bằng: А. Y. Goryainova, et al.
  Được phát hành: (2021-06-01)
• Mechanisms of metastasis and development of resistance to therapy in breast cancer. A clinical case of the effectiveness of ixabepilone in hormone-receptorpositive breast cancer with multidrug resistance
  Bằng: A. I. Stukan, et al.
  Được phát hành: (2021-08-01)
• Germinal <i>BRCA</i>-mutation significance in the tumor microenvironment formation Efficacy of PARP inhibition in late-line therapy of metastatic castration-resistant prostate cancer
  Bằng: A. I. Stukan, et al.
  Được phát hành: (2021-11-01)